Bora Pharmaceuticals Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Bobby Sheng
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 10.3yrs |
| Proprietà del CEO | 6.7% |
| Durata media del management | 7.2yrs |
| Durata media del Consiglio di amministrazione | 8.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem
Nov 21
Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?
Oct 04Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects
Jul 18Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?
Jun 13Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Apr 10Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality
Mar 14Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?
Mar 17Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment
Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)
Jan 27Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings
Dec 29Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?
Dec 09AMMINISTRATORE DELEGATO
Bobby Sheng
10.3yrs
Mandato
Mr. Pao-Shi Sheng, also known as Bobby, serves as Chairman of the Board at SunWay Biotech Co. LTD. since 2024. He Founder of Earth 88 and serves as its Chief Executive Officer.He serves as an Independent...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman | no data | Nessun dato | 6.72% NT$ 5.4b | |
| CFO of HQ & APAC | 11.8yrs | Nessun dato | Nessun dato | |
| Corporate Human Resource Director | 2.8yrs | Nessun dato | Nessun dato | |
| VP & Director | 11.6yrs | Nessun dato | 1.04% NT$ 834.2m | |
| Senior VP of Marketing and Sales - CDMO Business | no data | Nessun dato | Nessun dato | |
| CFO of North America | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Taiwan Site Operations | 1.8yrs | Nessun dato | Nessun dato | |
| Deputy General Manager | no data | Nessun dato | 0.0099% NT$ 8.0m | |
| Deputy General Manager | no data | Nessun dato | 0.067% NT$ 54.1m |
7.2yrs
Durata media
Gestione esperta: Il team dirigenziale di 6472 è esperto e expertise (durata media dell'incarico 7.2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman | 10.3yrs | Nessun dato | 6.72% NT$ 5.4b | |
| VP & Director | 10.3yrs | Nessun dato | 1.04% NT$ 834.2m | |
| Independent Director | 9.6yrs | Nessun dato | Nessun dato | |
| Director | 10.3yrs | Nessun dato | Nessun dato | |
| Director | 5.4yrs | Nessun dato | Nessun dato | |
| Independent Director | 7.4yrs | Nessun dato | Nessun dato | |
| Independent Director | 7.4yrs | Nessun dato | 0.028% NT$ 22.8m | |
| Independent Director | 1.4yrs | Nessun dato | 0% NT$ 0 |
8.5yrs
Durata media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 6472 sono considerati esperti (durata media dell'incarico 8.5 anni).